ArticleFrontiers in immunology2026

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report.

Mantas Vaisvilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.